TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
DELAYED 1 MONTH
54 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 9:09 PM | Richard DaniellEVP, Europe Commercial | Sale | 128,985 | $32.36 | $4.2M | 123,127(D) | View → |
| Mar 3, 2026 | Mar 5 9:06 PM | Brian SavageInterim Chief Legal Officer | Sale | 1,274 | $32.36 | $41.2K | 2,926(D) | View → |
| Mar 3, 2026 | Mar 5 9:05 PM | Richard D FrancisPresident and CEO | Sale | 442,935 | $32.36 | $14.3M | 1,121,382(D) | View → |
| Mar 3, 2026 | Mar 5 9:01 PM | Eric A HughesSee "Remarks" | Sale | 80,762 | $32.36 | $2.6M | 85,616(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 18 8:02 PM | Evan LippmanEVP, Business Development | Option Exercise | 85,849 | — | 74,008(D) | View → |
| Mar 5, 2026 | Mar 9 8:23 PM | Mark SabagSee "Remarks" | Option Exercise | 15,723 | — | 47,170(D) | View → |
| Mar 5, 2026 | Mar 9 8:22 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Option Exercise | 19,916 | — | 59,748(D) | View → |
| Mar 5, 2026 | Mar 9 8:19 PM | Amir WeissChief Accounting Officer | Option Exercise | 3,537 | — | 10,613(D) | View → |
| Mar 5, 2026 | Mar 9 8:18 PM | Richard D FrancisPresident and CEO | Option Exercise | 42,452 | — | 127,359(D) | View → |
| Mar 5, 2026 | Mar 9 8:16 PM | Christine FoxEVP, U.S. Commercial | Option Exercise | 17,819 | — | 53,459(D) | View → |
| Mar 5, 2026 | Mar 9 8:14 PM | Eric A HughesSee "Remarks" | Option Exercise | 19,654 | — | 58,962(D) | View → |
| Mar 5, 2026 | Mar 9 8:12 PM | Richard DaniellEVP, Europe Commercial | Option Exercise | 17,295 | — | 51,887(D) | View → |
| Mar 5, 2026 | Mar 9 8:10 PM | Placid JoverSee "Remarks" | Option Exercise | 14,150 | — | 42,453(D) | View → |
| Mar 5, 2026 | Mar 9 8:09 PM | Brian SavageInterim Chief Legal Officer | Option Exercise | 3,580 | — | 10,740(D) | View → |
| Mar 5, 2026 | Mar 9 8:05 PM | Matthew ShieldsEVP, Global Operations | Option Exercise | 17,295 | — | 51,887(D) | View → |
| Mar 4, 2026 | Mar 6 9:19 PM | Richard D FrancisPresident and CEO | Option Exercise | 50,223 | — | 100,446(D) | View → |
| Mar 4, 2026 | Mar 6 9:19 PM | Richard D FrancisPresident and CEO | Grant/Award | 136,736 | — | 136,736(D) | View → |
| Mar 4, 2026 | Mar 6 9:17 PM | Richard DaniellEVP, Europe Commercial | Grant/Award | 33,424 | — | 33,424(D) | View → |
| Mar 4, 2026 | Mar 6 9:17 PM | Richard DaniellEVP, Europe Commercial | Option Exercise | 53,973 | — | 40,923(D) | View → |
| Mar 4, 2026 | Mar 6 9:16 PM | Placid JoverSee "Remarks" | Grant/Award | 37,982 | — | 37,982(D) | View → |
| Mar 4, 2026 | Mar 6 9:14 PM | Matthew ShieldsEVP, Global Operations | Grant/Award | 33,424 | — | 33,424(D) | View → |
| Mar 4, 2026 | Mar 6 9:13 PM | Mark SabagSee "Remarks" | Grant/Award | 30,385 | — | 30,385(D) | View → |
| Mar 4, 2026 | Mar 6 9:13 PM | Mark SabagSee "Remarks" | Option Exercise | 52,113 | — | 37,202(D) | View → |
| Mar 4, 2026 | Mar 6 9:11 PM | Evan LippmanEVP, Business Development | Grant/Award | 27,347 | — | 27,347(D) | View → |